X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
adult (3) 3
aged (3) 3
humans (3) 3
middle aged (3) 3
diagnosis (2) 2
drug therapy (2) 2
female (2) 2
follow-up studies (2) 2
index medicus (2) 2
lymphomas (2) 2
male (2) 2
medicine, general & internal (2) 2
patients (2) 2
survival (2) 2
treatment outcome (2) 2
aberrations (1) 1
abnormalities (1) 1
abridged index medicus (1) 1
adolescent (1) 1
aged, 80 and over (1) 1
analysis (1) 1
antimetabolites, antineoplastic - adverse effects (1) 1
antimetabolites, antineoplastic - therapeutic use (1) 1
antineoplastic combined chemotherapy protocols - adverse effects (1) 1
antineoplastic combined chemotherapy protocols - therapeutic use (1) 1
apparent polycythemia (1) 1
b-cell lymphoma (1) 1
central nervous system diseases (1) 1
central nervous system neoplasms - drug therapy (1) 1
central nervous system neoplasms - mortality (1) 1
central nervous system neoplasms - radiotherapy (1) 1
central-nervous-system (1) 1
cerebrospinal-fluid (1) 1
chemoimmunotherapy (1) 1
chemotherapy (1) 1
chop (1) 1
chronic lymphatic leukemia (1) 1
cll (1) 1
combined modality therapy (1) 1
consolidating radiotherapy (1) 1
cranial irradiation - methods (1) 1
cross-sectional studies (1) 1
cyclophosphamide (1) 1
cytarabine (1) 1
cytarabine - adverse effects (1) 1
cytarabine - therapeutic use (1) 1
data analysis (1) 1
data collection (1) 1
deferred radiotherapy (1) 1
development and progression (1) 1
dexamethasone (1) 1
disease (1) 1
disease progression (1) 1
dosage and administration (1) 1
drug administration schedule (1) 1
drug therapy, combination (1) 1
elderly-patients (1) 1
epidemiology (1) 1
european organization (1) 1
fludarabine (1) 1
guidelines (1) 1
hematocrit (1) 1
hematology (1) 1
hematology, oncology and palliative medicine (1) 1
iii trial (1) 1
immunologic factors - adverse effects (1) 1
immunologic factors - therapeutic use (1) 1
initial treatment (1) 1
internal medicine (1) 1
international workshop (1) 1
italy - epidemiology (1) 1
kaplan-meier estimate (1) 1
lesions (1) 1
leukemia (1) 1
logistic models (1) 1
lymphocytic leukemia (1) 1
lymphoma, large b-cell, diffuse - drug therapy (1) 1
lymphoma, non-hodgkin - drug therapy (1) 1
lymphoma, non-hodgkin - mortality (1) 1
lymphoma, non-hodgkin - radiotherapy (1) 1
management (1) 1
medical disorders (1) 1
medical research (1) 1
methotrexate (1) 1
methotrexate - adverse effects (1) 1
methotrexate - therapeutic use (1) 1
minnesota (1) 1
monoclonal antibodies (1) 1
neoplasm recurrence, local - drug therapy (1) 1
neutropenia - chemically induced (1) 1
non-hodgkin-lymphoma (1) 1
non-hodgkins-lymphoma (1) 1
olmsted county (1) 1
oncology (1) 1
open-label (1) 1
oxaliplatin (1) 1
p53 protein (1) 1
patient outcomes (1) 1
platelet count (1) 1
polycythemia - complications (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2009, Volume 374, Issue 9700, pp. 1512 - 1520
Summary Background Chemotherapy with high-dose methotrexate is the conventional approach to treat primary CNS lymphomas, but superiority of polychemotherapy... 
Internal Medicine | DEFERRED RADIOTHERAPY | MEDICINE, GENERAL & INTERNAL | B-CELL LYMPHOMA | INTERNATIONAL WORKSHOP | RESPONSE CRITERIA | EUROPEAN ORGANIZATION | CONSOLIDATING RADIOTHERAPY | NON-HODGKINS-LYMPHOMA | INITIAL TREATMENT | CENTRAL-NERVOUS-SYSTEM | CEREBROSPINAL-FLUID | Follow-Up Studies | Cytarabine - therapeutic use | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Cytarabine - adverse effects | Methotrexate - therapeutic use | Lymphoma, Non-Hodgkin - radiotherapy | Cranial Irradiation - methods | Central Nervous System Neoplasms - radiotherapy | Adult | Lymphoma, Non-Hodgkin - drug therapy | Drug Administration Schedule | Kaplan-Meier Estimate | Proportional Hazards Models | Logistic Models | Treatment Outcome | Combined Modality Therapy | Remission Induction | Methotrexate - adverse effects | Antimetabolites, Antineoplastic - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Antimetabolites, Antineoplastic - adverse effects | Aged | Lymphoma, Non-Hodgkin - mortality | Central Nervous System Neoplasms - drug therapy | Central Nervous System Neoplasms - mortality | Cytarabine | Patient outcomes | Central nervous system diseases | Dosage and administration | Lymphomas | Drug therapy, Combination | Methotrexate | Drug therapy | Data analysis | Disease | Monoclonal antibodies | Data collection | Radiation therapy | Patients | Tropical diseases | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.